Discoveries in Health Policy

Ideas for or from an evolving healthcare system

Saturday, October 10, 2026

Sepsis: ARPA Grant for Treatable Subtypes; Review

›
ARPA-H Backs a Precision-Immunology Platform for the ICU An award of up to $41.4 million will support a Stanford-led effort to measure chang...
Friday, October 9, 2026

The Stark Law and Pathologist-Owned Labs...and IHC Orders

›
We all know that the Stark law prohibits doctors from referring lab tests to labs they have an ownership in.   How about the daily occurence...

AI Reviews: Three-Day Value Based Cancer Care Conference (VBCC), NYT October 2026

›
  AVBCC 2026 and the work of making cancer care deliver value The 2026 summit of the Association for Value-Based Cancer Care , scheduled for...
Thursday, October 8, 2026

Winds of Change: Triangulating the Roles of Pathologists, Radiologists, Oncologists in an AI World

›
(Guest Author: Chat GPT 6, using Sol 6.1 High.)  We previously did a deep dive article on Socarraz & Lennerz, a vision for fundamental c...

Woodcock et al: A Plan to Turbocharge National Precision Oncology

›
 https://pubmed.ncbi.nlm.nih.gov/42842867/ (Chat GPT; article is open access.)   Former FDA Leader Woodcock Calls for National Effort to Clo...

Brief Blog: How Whole Slide Imaging Codes Fared in PAMA

›
Header: I spot-checked 9 PLA codes that include whole slide imaging (sometimes naming computer interpretation) and only 1 of 9 has PAMA repr...
Wednesday, October 7, 2026

Can AI help discover new quality measures for oncology?

›
In some circles, you hear that we need new better quality measures in oncology, but it's not always clear how to go about discovering th...

CMS Wants Your Views on its Fraud Contractors (UPICs etc)

›
Earlier this year, CMS posted an RFI on its "CRUSH" anti fraud scale-up.  CMS has generated a proposed rule now percolating at OMB...
Monday, October 5, 2026

PAMA: What Happened to Exome, Genome, and NIPT?

›
 Under PAMA, what happens to Exome, Genome, and NIPT beginning in 2027? Here's the data, click to enlarge: click to enlarge Exome 2018  ...

PLA Use of "100 genes or more." It's baaaack!

›
 For several years, there seemed to be a PLA moratorium on the use of "or more" so you'd see the construction "Panel of 8...

CMS Issues New October PLA Codes, New October Clin Lab Fee Schedule CLFS. Essay on "Or More."

›
CMS has released the October 1, or fourth-quarter, Clin Lab Fee Schedule, CLFS.   The next one, on January 1, will be based on PAMA prices. ...

FDA Awards $1M for Approval Methods for AI Radiology Reports. Will AI Pathology Reports be Far Behind?

›
I've argued that the billion-dollar app in digital pathology will be an FDA-cleared app for draft report preparation.  (The pathologist ...
Sunday, October 4, 2026

Understanding Sparano via Understanding the "C Statistic"

›
The adjacent blog about the Oncotype test and Sparano's new IICM+ test, pivots almost every quantitative comparison on "C-statistic...
›
Home
View web version

About the Author

My photo
Bruce
Bruce Quinn MD PhD is an expert on health reform, innovation, and Medicare policy. He helps both large and small companies understand and overcome hurdles to commercialization, as well as craft business strategies for a changing environment. CONTACT Dr. Quinn through www.brucequinn.com. BACKGROUND: Dr. Quinn has worked in academic medicine, Accenture business strategies, and for the Medicare program. EDUCATION: Stanford MD/PhD, MIT Postdoc, Kellogg MBA.
View my complete profile
Powered by Blogger.